Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
International Immunopharmacology|September 4, 2025
IL4I1 attenuates myocardial infarction by inhibiting macrophage ferroptosis via the I3P/AHR/NRF2 signaling pathwayChen Dong, Rui Shen, Yan Ding, et al.
International Journal of Molecular Medicine|December 29, 2022
Ablation of CXCR4 expression in cardiomyocytes exacerbates isoproterenol‑induced cell death and heart failureMin Cheng, Can Chen, Kunwu Yu, et al.
Mediators of Inflammation|July 11, 2015
Chemerin15-Ameliorated Cardiac Ischemia-Reperfusion Injury Is Associated with the Induction of Alternatively Activated MacrophagesChao Chang, Qingwei Ji, Bangwei Wu, et al.
Biochemical and Biophysical Research Communications|February 17, 2026
Identification and experimental confirmation of TBC1D10C as a shared transcriptional link between abdominal aortic aneurysm and major depressive disorderChen Dong, Jianhua Xie, Rui Shen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 7, 2024
Primary Aldosteronism Influences Cardiac Structure, Function, and Disease Risk: Evidence From Mendelian Randomization AnalysisRui Shen, Chengliang Pan, Jian Yu, et al.
International Immunopharmacology|October 24, 2024
Interleukin-38 ameliorates myocardial Ischemia-Reperfusion injury via inhibition of NLRP3 inflammasome activation in fibroblasts through the IL-1R8/SYK axisChengliang Pan, Rui Shen, Yan Ding, et al.
Clinical Immunology (Orlando, Fla.)|September 9, 2023
Latency-associated peptide (LAP)+CD4+ regulatory T cells prevent atherosclerosis by modulating macrophage polarizationJian Yu, Wenbin Xu, Qian Dong, et al.
Biomolecules|December 30, 2025
Interleukin-38 Ameliorates Atherosclerosis by Inhibiting Macrophage M1-like Polarization and ApoptosisZhiyang Li, Xuelian Li, Rui Shen, et al.
Metabolites|July 26, 2024
Type 2 Diabetes, Circulating Metabolites, and Calcific Aortic Valve Stenosis: A Mendelian Randomization StudyRui Shen, Chengliang Pan, Guiwen Yi, et al.
Mediators of Inflammation|November 21, 2022
Interleukin-27 Ameliorates Atherosclerosis in ApoE-/- Mice through Regulatory T Cell Augmentation and Dendritic Cell ToleranceWenbin Xu, Ruirui Zhu, Zhengfeng Zhu, et al.
Pageof 5